Literature DB >> 23986532

Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses.

Lei Huang1, Lingqian Li, Henrique Lemos, Phillip R Chandler, Gabriela Pacholczyk, Babak Baban, Glen N Barber, Yoshihiro Hayakawa, Tracy L McGaha, Buvana Ravishankar, David H Munn, Andrew L Mellor.   

Abstract

Cytosolic DNA sensing via the stimulator of IFN genes (STING) adaptor incites autoimmunity by inducing type I IFN (IFN-αβ). In this study, we show that DNA is also sensed via STING to suppress immunity by inducing IDO. STING gene ablation abolished IFN-αβ and IDO induction by dendritic cells (DCs) after DNA nanoparticle (DNP) treatment. Marginal zone macrophages, some DCs, and myeloid cells ingested DNPs, but CD11b(+) DCs were the only cells to express IFN-β, whereas CD11b(+) non-DCs were major IL-1β producers. STING ablation also abolished DNP-induced regulatory responses by DCs and regulatory T cells, and hallmark regulatory responses to apoptotic cells were also abrogated. Moreover, systemic cyclic diguanylate monophosphate treatment to activate STING induced selective IFN-β expression by CD11b(+) DCs and suppressed Th1 responses to immunization. Thus, previously unrecognized functional diversity among physiologic innate immune cells regarding DNA sensing via STING is pivotal in driving immune responses to DNA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986532      PMCID: PMC3788571          DOI: 10.4049/jimmunol.1301419

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  IFI16 is an innate immune sensor for intracellular DNA.

Authors:  Leonie Unterholzner; Sinead E Keating; Marcin Baran; Kristy A Horan; Søren B Jensen; Shruti Sharma; Cherilyn M Sirois; Tengchuan Jin; Eicke Latz; T Sam Xiao; Katherine A Fitzgerald; Søren R Paludan; Andrew G Bowie
Journal:  Nat Immunol       Date:  2010-10-03       Impact factor: 25.606

2.  Differential antigen processing by dendritic cell subsets in vivo.

Authors:  Diana Dudziak; Alice O Kamphorst; Gordon F Heidkamp; Veit R Buchholz; Christine Trumpfheller; Sayuri Yamazaki; Cheolho Cheong; Kang Liu; Han-Woong Lee; Chae Gyu Park; Ralph M Steinman; Michel C Nussenzweig
Journal:  Science       Date:  2007-01-05       Impact factor: 47.728

3.  The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides.

Authors:  John-Demian Sauer; Katia Sotelo-Troha; Jakob von Moltke; Kathryn M Monroe; Chris S Rae; Sky W Brubaker; Mamoru Hyodo; Yoshihiro Hayakawa; Joshua J Woodward; Daniel A Portnoy; Russell E Vance
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

4.  Physiologic control of IDO competence in splenic dendritic cells.

Authors:  Babak Baban; Phillip R Chandler; Burles A Johnson; Lei Huang; Minghui Li; Marlon L Sharpe; Loise M Francisco; Arlene H Sharpe; Bruce R Blazar; David H Munn; Andrew L Mellor
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

5.  The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse.

Authors:  Masato Hoshi; Kuniaki Saito; Akira Hara; Ayako Taguchi; Hirofumi Ohtaki; Ryo Tanaka; Hidetsugu Fujigaki; Yosuke Osawa; Masao Takemura; Hidetoshi Matsunami; Hiroyasu Ito; Mitsuru Seishima
Journal:  J Immunol       Date:  2010-08-06       Impact factor: 5.422

6.  The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells.

Authors:  Zhiqiang Zhang; Bin Yuan; Musheng Bao; Ning Lu; Taeil Kim; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2011-09-04       Impact factor: 25.606

7.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity.

Authors:  Hiroki Ishikawa; Zhe Ma; Glen N Barber
Journal:  Nature       Date:  2009-09-23       Impact factor: 49.962

8.  HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA.

Authors:  Tara L Roberts; Adi Idris; Jasmyn A Dunn; Greg M Kelly; Carol M Burnton; Samantha Hodgson; Lani L Hardy; Valerie Garceau; Matthew J Sweet; Ian L Ross; David A Hume; Katryn J Stacey
Journal:  Science       Date:  2009-01-08       Impact factor: 47.728

9.  Structural mechanism of cytosolic DNA sensing by cGAS.

Authors:  Filiz Civril; Tobias Deimling; Carina C de Oliveira Mann; Andrea Ablasser; Manuela Moldt; Gregor Witte; Veit Hornung; Karl-Peter Hopfner
Journal:  Nature       Date:  2013-05-30       Impact factor: 49.962

10.  Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans.

Authors:  Elin Jaensson; Heli Uronen-Hansson; Oliver Pabst; Bertus Eksteen; Jiong Tian; Janine L Coombes; Pia-Lena Berg; Thomas Davidsson; Fiona Powrie; Bengt Johansson-Lindbom; William W Agace
Journal:  J Exp Med       Date:  2008-08-18       Impact factor: 14.307

View more
  66 in total

Review 1.  Translating nucleic acid-sensing pathways into therapies.

Authors:  Tobias Junt; Winfried Barchet
Journal:  Nat Rev Immunol       Date:  2015-08-21       Impact factor: 53.106

2.  Triggering of the cGAS-STING Pathway in Human Plasmacytoid Dendritic Cells Inhibits TLR9-Mediated IFN Production.

Authors:  Pratik Deb; Jihong Dai; Sukhwinder Singh; Evelyne Kalyoussef; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2020-05-29       Impact factor: 5.422

3.  Suppression of systemic autoimmunity by the innate immune adaptor STING.

Authors:  Shruti Sharma; Allison M Campbell; Jennie Chan; Stefan A Schattgen; Gregory M Orlowski; Ribhu Nayar; Annie H Huyler; Kerstin Nündel; Chandra Mohan; Leslie J Berg; Mark J Shlomchik; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

4.  Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice.

Authors:  Henrique Lemos; Eslam Mohamed; Lei Huang; Phillip R Chandler; Rong Ou; Rafal Pacholczyk; Andrew L Mellor
Journal:  Immunology       Date:  2019-10-15       Impact factor: 7.397

Review 5.  Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences.

Authors:  Diwakar Davar; Nathan Bahary
Journal:  Target Oncol       Date:  2018-04       Impact factor: 4.493

Review 6.  Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Authors:  Erika Vacchelli; Norma Bloy; Fernando Aranda; Aitziber Buqué; Isabelle Cremer; Sandra Demaria; Alexander Eggermont; Silvia Chiara Formenti; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

Review 7.  Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA.

Authors:  Henrique Lemos; Lei Huang; Tracy L McGaha; Andrew L Mellor
Journal:  Eur J Immunol       Date:  2014-08-25       Impact factor: 5.532

Review 8.  Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.

Authors:  Theodore S Johnson; Tracy Mcgaha; David H Munn
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 9.  DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Authors:  Søren R Paludan; Line S Reinert; Veit Hornung
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

10.  Polyplexes assembled from self-peptides and regulatory nucleic acids blunt toll-like receptor signaling to combat autoimmunity.

Authors:  Krystina L Hess; James I Andorko; Lisa H Tostanoski; Christopher M Jewell
Journal:  Biomaterials       Date:  2016-11-30       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.